| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 226.5× | 27.9× | |
| Price / Book | 12.6× | 4.1× | |
| Price / Sales | 12.7× | 2.9× | |
| Price / Free cash flow | 125.7× | −12.3× | |
| EV / EBITDA | 60.4× | 21.7× | |
| Earnings yield | 0.4% | 2.1% | |
| Free cash flow yield | 0.8% | −3.3% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
RUNSE:RUBICONRubicon Research Ltd · 🇮🇳 NSE | ₹1,477.40 | −2.07% | $2.52B | 99.0× | 19.1% | — |
MONSE:MOLBIOMolbio Diagnostics Limited · 🇮🇳 NSE | ₹1,465.20 | −6.94% | $1.61B | 113.4× | 15.0% | — |
CONSE:CORONACorona Remedies Ltd · 🇮🇳 NSE | ₹2,017.00 | +0.65% | $1.32B | 67.6× | 24.8% | — |
SYNSE:SYMBIOTECSymbiotec Pharmalab Limited · 🇮🇳 NSE | ₹1,273.60 | −0.46% | $845.11M | 83.4× | 11.9% | — |
KPNSE:KPLKwality Pharmaceuticals Ltd · 🇮🇳 NSE | ₹3,369.60 | −0.98% | $358.43M | 51.1× | 20.3% | — |
SHNSE:SHUKRAPHARShukra Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹68.53 | −0.51% | $307.12M | 133.1× | 24.5% | — |
FRNSE:FREDUNFredun Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹1,435.10 | −2.88% | $245.22M | 73.6× | 11.7% | — |
SANSE:SAIPARENTSai Parenteral's Ltd · 🇮🇳 NSE | ₹484.00 | −0.68% | $223.33M | 149.9× | 2.9% | — |
BENSE:BETABeta Drugs Ltd · 🇮🇳 NSE | ₹1,737.80 | −2.54% | $198.91M | 46.8× | 16.9% | −2.0% |
VONSE:VOEPLVirtuoso OptoElectronics Ltd · 🇮🇳 NSE | ₹531.25 | +3.96% | $188.54M | 114.8× | 3.6% | — |
